$ORIC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oric Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Oric Pharmaceuticals, Inc.. Get notifications about new insider transactions in Oric Pharmaceuticals, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | A | 19.03 | 16,625 | 316,374 | 16,625 | |
Jun 17 2021 | ORIC | Oric Pharmaceutica ... | Kunkel Lori Anne | Director | Option Exercise | A | 19.03 | 16,625 | 316,374 | 16,625 | |
May 28 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.07 | 400 | 10,028 | 22,732 | 23.1 K to 22.7 K (-1.73 %) |
May 24 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.00 | 100 | 2,500 | 219,826 | 219.9 K to 219.8 K (-0.05 %) |
May 24 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.25 | 600 | 15,150 | 219,926 | 220.5 K to 219.9 K (-0.27 %) |
May 24 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.08 | 700 | 17,558 | 220,526 | 221.2 K to 220.5 K (-0.32 %) |
May 24 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.00 | 100 | 2,500 | 39,092 | 39.2 K to 39.1 K (-0.26 %) |
May 24 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.19 | 1,231 | 31,008 | 39,192 | 40.4 K to 39.2 K (-3.05 %) |
May 24 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.08 | 659 | 16,528 | 40,423 | 41.1 K to 40.4 K (-1.60 %) |
May 18 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.32 | 2,161 | 54,715 | 221,226 | 223.4 K to 221.2 K (-0.97 %) |
May 18 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.07 | 498 | 12,484 | 223,387 | 223.9 K to 223.4 K (-0.22 %) |
May 18 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.31 | 3,215 | 81,382 | 223,885 | 227.1 K to 223.9 K (-1.42 %) |
May 18 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.34 | 2,800 | 70,958 | 41,082 | 43.9 K to 41.1 K (-6.38 %) |
May 18 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.06 | 500 | 12,530 | 43,882 | 44.4 K to 43.9 K (-1.13 %) |
May 18 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.38 | 4,615 | 117,117 | 44,382 | 49 K to 44.4 K (-9.42 %) |
May 13 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.11 | 100 | 2,511 | 227,100 | 227.2 K to 227.1 K (-0.04 %) |
May 13 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.00 | 100 | 2,500 | 48,997 | 49.1 K to 49 K (-0.20 %) |
May 13 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.00 | 103 | 2,575 | 49,097 | 49.2 K to 49.1 K (-0.21 %) |
May 13 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.16 | 300 | 7,548 | 49,200 | 49.5 K to 49.2 K (-0.61 %) |
May 13 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.04 | 730 | 18,281 | 58,180 | 58.9 K to 58.2 K (-1.24 %) |
May 13 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.02 | 400 | 10,010 | 58,910 | 59.3 K to 58.9 K (-0.67 %) |
May 13 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.22 | 1,090 | 27,490 | 59,310 | 60.4 K to 59.3 K (-1.80 %) |
Apr 30 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.26 | 100 | 2,526 | 227,200 | 227.3 K to 227.2 K (-0.04 %) |
Apr 30 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.08 | 100 | 2,508 | 227,300 | 227.4 K to 227.3 K (-0.04 %) |
Apr 30 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.19 | 100 | 2,519 | 49,500 | 49.6 K to 49.5 K (-0.20 %) |
Apr 30 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.11 | 200 | 5,022 | 49,600 | 49.8 K to 49.6 K (-0.40 %) |
Apr 30 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.24 | 600 | 15,143 | 60,400 | 61 K to 60.4 K (-0.98 %) |
Apr 30 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.06 | 700 | 17,542 | 61,000 | 61.7 K to 61 K (-1.13 %) |
Apr 05 2021 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Sell | S | 25.00 | 200 | 5,000 | 49,800 | 50 K to 49.8 K (-0.40 %) |
Apr 05 2021 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Sell | S | 25.00 | 100 | 2,500 | 227,400 | 227.5 K to 227.4 K (-0.04 %) |
Apr 05 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Sell | S | 25.09 | 800 | 20,070 | 61,700 | 62.5 K to 61.7 K (-1.28 %) |
Mar 31 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.93 | 27,869 | 666,905 | 2,212,571 | 2.2 M to 2.2 M (-1.24 %) |
Mar 31 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.31 | 75,555 | 1,761,187 | 2,240,440 | 2.3 M to 2.2 M (-3.26 %) |
Mar 31 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.93 | 27,869 | 666,905 | 2,212,571 | 2.2 M to 2.2 M (-1.24 %) |
Mar 31 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.31 | 75,555 | 1,761,187 | 2,240,440 | 2.3 M to 2.2 M (-3.26 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.32 | 3,992 | 97,085 | 2,428,293 | 2.4 M to 2.4 M (-0.16 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 26.47 | 7,673 | 203,104 | 2,432,285 | 2.4 M to 2.4 M (-0.31 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 26.47 | 21,275 | 563,149 | 2,439,958 | 2.5 M to 2.4 M (-0.86 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.32 | 3,992 | 97,085 | 2,428,293 | 2.4 M to 2.4 M (-0.16 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 26.47 | 7,673 | 203,104 | 2,432,285 | 2.4 M to 2.4 M (-0.31 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 26.47 | 21,275 | 563,149 | 2,439,958 | 2.5 M to 2.4 M (-0.86 %) |
Mar 18 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 28.03 | 6,059 | 169,834 | 2,461,233 | 2.5 M to 2.5 M (-0.25 %) |
Mar 18 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 28.43 | 18,790 | 534,200 | 2,467,292 | 2.5 M to 2.5 M (-0.76 %) |
Mar 18 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 27.72 | 41,353 | 1,146,305 | 2,486,082 | 2.5 M to 2.5 M (-1.64 %) |
Mar 18 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 28.03 | 6,059 | 169,834 | 2,461,233 | 2.5 M to 2.5 M (-0.25 %) |
Mar 18 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 28.43 | 18,790 | 534,200 | 2,467,292 | 2.5 M to 2.5 M (-0.76 %) |
Mar 18 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 27.72 | 41,353 | 1,146,305 | 2,486,082 | 2.5 M to 2.5 M (-1.64 %) |
Mar 15 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 29.14 | 89,210 | 2,599,579 | 2,527,435 | 2.6 M to 2.5 M (-3.41 %) |
Mar 15 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 30.29 | 90,521 | 2,741,881 | 2,616,645 | 2.7 M to 2.6 M (-3.34 %) |
Mar 15 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 33.04 | 58,551 | 1,934,525 | 2,707,166 | 2.8 M to 2.7 M (-2.12 %) |
Mar 15 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 29.14 | 89,210 | 2,599,579 | 2,527,435 | 2.6 M to 2.5 M (-3.41 %) |
Mar 15 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 30.29 | 90,521 | 2,741,881 | 2,616,645 | 2.7 M to 2.6 M (-3.34 %) |
Mar 15 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 33.04 | 58,551 | 1,934,525 | 2,707,166 | 2.8 M to 2.7 M (-2.12 %) |
Feb 02 2021 | ORIC | Oric Pharmaceutica ... | Piscitelli Dominic | Chief Financial Off ... | Option Exercise | A | 29.83 | 90,000 | 2,684,700 | 90,000 | |
Feb 02 2021 | ORIC | Oric Pharmaceutica ... | Multani Pratik S | Chief Medical Offic ... | Option Exercise | A | 29.83 | 90,000 | 2,684,700 | 90,000 | |
Feb 02 2021 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Option Exercise | A | 29.83 | 280,000 | 8,352,400 | 280,000 | |
Nov 05 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Sell | S | 0.00 | 2,268,750 | 0 | 1,100,446 | 3.4 M to 1.1 M (-67.34 %) |
Jun 10 2020 | ORIC | Oric Pharmaceutica ... | Kunkel Lori Anne | Director | Option Exercise | A | 35.92 | 28,515 | 1,024,259 | 28,515 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 151,515 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 416,666 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 625,000 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 3,500,000 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 151,515 | 0 | 4,768,181 | 4.6 M to 4.8 M (+3.28 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 416,666 | 0 | 4,616,666 | 4.2 M to 4.6 M (+9.92 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 625,000 | 0 | 4,200,000 | 3.6 M to 4.2 M (+17.48 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Buy | C | 0.00 | 3,500,000 | 0 | 3,575,000 | 75 K to 3.6 M (+4,666.67 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 236,111 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 373,356 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,875,000 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 236,111 | 0 | 2,765,717 | 2.5 M to 2.8 M (+9.33 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 373,356 | 0 | 2,529,606 | 2.2 M to 2.5 M (+17.32 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,875,000 | 0 | 2,156,250 | 281.3 K to 2.2 M (+666.67 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 281,250 | 4,500,000 | 281,250 | 0 to 281.3 K |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,268,750 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 314,815 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 497,809 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 231,250 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Buy | C | 0.00 | 2,268,750 | 0 | 2,268,750 | 0 to 2.3 M |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Buy | C | 0.00 | 314,815 | 0 | 1,043,874 | 729.1 K to 1 M (+43.18 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Buy | C | 0.00 | 497,809 | 0 | 729,059 | 231.3 K to 729.1 K (+215.27 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Topspin Fund L.P. | 10% Owner | Buy | C | 0.00 | 231,250 | 0 | 231,250 | 0 to 231.3 K |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 151,515 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 416,666 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 625,000 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 3,500,000 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Buy | C | 0.00 | 151,515 | 0 | 4,768,181 | 4.6 M to 4.8 M (+3.28 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Buy | C | 0.00 | 416,666 | 0 | 4,616,666 | 4.2 M to 4.6 M (+9.92 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Buy | C | 0.00 | 625,000 | 0 | 4,200,000 | 3.6 M to 4.2 M (+17.48 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Buy | C | 0.00 | 3,500,000 | 0 | 3,575,000 | 75 K to 3.6 M (+4,666.67 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Buy | C | 0.00 | 25,000 | 0 | 50,000 | 25 K to 50 K (+100.00 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Option Exercise | C | 0.00 | 62,500 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Buy | C | 0.00 | 62,500 | 0 | 227,500 | 165 K to 227.5 K (+37.88 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 236,111 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 373,356 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,875,000 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | C | 0.00 | 236,111 | 0 | 2,765,717 | 2.5 M to 2.8 M (+9.33 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | C | 0.00 | 373,356 | 0 | 2,529,606 | 2.2 M to 2.5 M (+17.32 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,875,000 | 0 | 2,156,250 | 281.3 K to 2.2 M (+666.67 %) |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Buy | P | 16.00 | 281,250 | 4,500,000 | 281,250 | 0 to 281.3 K |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Option Exercise | C | 0.00 | 62,500 | 0 | 0 | |
Apr 28 2020 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Buy | C | 0.00 | 62,500 | 0 | 62,500 | 0 to 62.5 K |
Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Multani Pratik S | Chief Medical Offic ... | Option Exercise | A | 16.00 | 147,500 | 2,360,000 | 147,500 | |
Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Piscitelli Dominic | Chief Financial Off ... | Option Exercise | A | 16.00 | 86,250 | 1,380,000 | 86,250 | |
Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Dier Mardi | Director | Option Exercise | A | 16.00 | 33,250 | 532,000 | 33,250 | |
Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Svennilson Peter | Director | Option Exercise | A | 16.00 | 16,625 | 266,000 | 16,625 | |
Apr 27 2020 | ORIC | Oric Pharmaceutica ... | SCHELLER RICHARD H | Director | Option Exercise | A | 16.00 | 33,250 | 532,000 | 33,250 | |
Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Heyman Richard A. | Director | Option Exercise | A | 16.00 | 16,625 | 266,000 | 16,625 | |
Apr 27 2020 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Option Exercise | A | 16.00 | 16,625 | 266,000 | 16,625 | |
Apr 27 2020 | ORIC | Oric Pharmaceutica ... | Chacko Jacob | President and CEO | Option Exercise | A | 16.00 | 437,500 | 7,000,000 | 437,500 |
Page: 1